Monthly Archives: November 2016

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Gluten ingestion leads to symptoms and small intestinal mucosal injury in patients with celiac disease. The only option is the strict lifelong exclusion of dietary gluten, which is difficult to accomplish. Many patients following a gluten-free diet con… Continue reading

Posted in News | Comments Off on No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Hypermutation In Pancreatic Cancer

Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden and defective DNA repair are associated with response to immune checkpoint inhibitors in several other cancer types. We interrogated 385 pancreatic cancer… Continue reading

Posted in News | Comments Off on Hypermutation In Pancreatic Cancer

Hypermutation In Pancreatic Cancer

Pancreatic cancer is molecularly diverse, with few effective therapies. Increased mutation burden and defective DNA repair are associated with response to immune checkpoint inhibitors in several other cancer types. We interrogated 385 pancreatic cancer… Continue reading

Posted in News | Comments Off on Hypermutation In Pancreatic Cancer

American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection

This document presents the official recommendations of the American Gastroenterological Association (AGA) on the management of Crohn’s disease (CD) after surgical resection. The guideline was developed by the AGA’s Clinical Guidelines Committee and… Continue reading

Posted in News | Comments Off on American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection

American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection

This document presents the official recommendations of the American Gastroenterological Association (AGA) on the management of Crohn’s disease (CD) after surgical resection. The guideline was developed by the AGA’s Clinical Guidelines Committee and… Continue reading

Posted in News | Comments Off on American Gastroenterological Association Institute Guideline on the Management of Crohn’s Disease After Surgical Resection

American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection

Crohn’s disease (CD) is a chronic, disabling gastrointestinal disease with a rising incidence and prevalence.1 Affecting approximately 1 in 300 people in the Western world, CD typically evolves from an inflammatory process into penetrating and fibros… Continue reading

Posted in News | Comments Off on American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection

American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection

Crohn’s disease (CD) is a chronic, disabling gastrointestinal disease with a rising incidence and prevalence.1 Affecting approximately 1 in 300 people in the Western world, CD typically evolves from an inflammatory process into penetrating and fibros… Continue reading

Posted in News | Comments Off on American Gastroenterological Association Institute Technical Review on the Management of Crohn’s Disease After Surgical Resection

Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation

Occult infection with hepatitis C virus (HCV) is defined as the presence of the HCV genome in either liver tissue or peripheral blood monocytes, despite constant negative results from tests for HCV RNA in serum. We investigated whether patients who mai… Continue reading

Posted in News | Comments Off on Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation

Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation

Occult infection with hepatitis C virus (HCV) is defined as the presence of the HCV genome in either liver tissue or peripheral blood monocytes, despite constant negative results from tests for HCV RNA in serum. We investigated whether patients who mai… Continue reading

Posted in News | Comments Off on Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation

Breath Testing for Barrett’s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device

To date, of the 5 human senses, smell has been the most underused in diagnostic medicine. This is not because of its lack of potential; numerous canine studies over the last 2 decades have demonstrated that odors can distinguish multiple benign and mal… Continue reading

Posted in News | Comments Off on Breath Testing for Barrett’s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device